HUM-MOLGEN events: Developing a Preclinical Outsourcing Strategy

HUM-MOLGEN -> Events -> Meetings and Conferences

Developing a Preclinical Outsourcing Strategy

September 16, 2003

Pharmaceutical Education Associates, Philadelphia, PA
Dec. 15-16, 2003

This exclusive event addresses critical issues including:

• Determining the Outsourcing Need: What is the Best Strategy to Suit Your Preclinical Needs?
• Implementing a Global Outsourcing Strategy for Toxicology after a Merger
• Preclinical Anatomic Pathology: What You Really Need to Know about Your CRO
• The Importance of Bridging Preclinical and Clinical Development
• Selecting the CRO: Information Gathering and Interviews, Site Visits, Scheduling Issues and Effective Communications
• Critical Issues that Must be Considered at the Contractual Stage
• The Outsourcing Relationship: Managing for Success
• and much more!

Don't miss the exclusive post-conference workshop:
Strategies for structuring contracts with preclinical outsourcing providers

Organized by:

Pharmaceutical Education Associates

Invited Speakers:

Andrew Aldridge, PhD
Director, Safety Assessment Affairs
ASTRAZENECA PLC

Wendel Barr
Corporate Vice President
President, Early Development
COVANCE INC

Nancy R. Contel, DVM
Principal Research Scientist, Preclinical Biology
INCYTE CORPORATION

Alex Fowkes, Esq
Senior Corporate Counsel, Legal Division
PFIZER, INC

Patrick J. Haley, DVM, PhD
Director, Preclinical Sciences
ASTRAZENECA

Steve Matheson
Senior Director, Preclinical Business Development
QUINTILES

Jack McLain, LATG
Manager, Contract Research Services
Drug Safety and Metabolism, Safety Evaluation Center
SCHERING-PLOUGH RESEARCH INSTITUTE

Jim I. McLoughlin, MBA, PhD
Global Portfolio Head, Strategic Alliances
Worldwide Safety Sciences
PFIZER GLOBAL R&D

Thomas J. Mercolino, PhD
Senior Director, Drug Discovery Contracts & Agreements
JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT

Merrill R. Osheroff, PhD, DABT
Executive Director & Site Head
Worldwide Safety Sciences-Kalamazoo
PFIZER GLOBAL RESEARCH AND DEVELOPMENT

Julie Pedelini
Senior Director, Compliance, Sourcing & Resource Management
Global Preclinical Development
JOHNSON & JOHNSON PHARMACEUTICAL R&D